📢NEW: RMP 2023-2024 Annual Report! . Proud to share RMP’s 2023-2024 Annual Report, highlighting a year of breakthrough research, world-class education, and exceptional patient care. Read: @UHN @pmcancercentre @thePMCF @UofTDRO @CancerCare_ON

RT @STARS21atUT: 🚨 Now open: Applications for the 2025–26 #STARS21 Program!.Build your future in translational & transdisciplinary radiatio….

RT @MarcBarcieMD: Sharing our recent publication on the use of altered fractionated IMRT diagnosed with locally advanced head and neck squa….

RT @CDNCancerTrials: The Ralph Meyer Phase III Program Young Investigator Award has been awarded to Dr. Rachel Glicksman from Princess Marg….

RT @CDNCancerTrials: We are honoured to announce that the Joseph Pater (@jpater45) Founder’s Award for Excellence in Clinical Trials Resear….

RT @UHN: Today UHN launches the Canada Leads 100 Challenge! 🇨🇦💯. We’re making an ambitious investment to recruit 100 world-leading scientis….

RT @CJTsaiMDPhD: 🚨📢Pleased to announce the activation of @CDNCancerTrials BR38 (CURB2, Ph3 SBRT for Oligoprogressive NSCLC, NCT06686771). T….

📢 Exciting news! Massey College & the Friends of @CIHR_IRSC are thrilled to announce Dr. @daniellerodin as the 2025 Janet Rossant Lecturer. The lectureship is part of the annual Massey Grand Rounds Symposium at Massey College. Congratulations! 🎉🎉#RMPatPM #RadOnc

SPOTLIGHT: Congratulations to Dr. Mary Gospodarowicz on being inducted as a Fellow of the American Society of Clinical Oncology (FASCO)! This well-deserved honour recognizes her extraordinary dedication and commitment to the Society and the field of oncology. 👏🎉

The study evaluates children undergoing re-irradiation for brainstem glioma and diffuse midline glioma—re-irradiation is an effective (albeit temporary) treatment that extends life and palliates symptoms. #RadOnc.

🎉 Congratulations to Drs. Derek Tsang, David Hodgson, Barbara Ann-Millar, and Dana M. Keilty on their newly published paper in Radiotherapy & Oncology! 👏. 🔗 Read here: #RadiationMedicine #CancerResearch #RMPatPM

From advancing cancer treatment innovations to training the next generation of experts, our multidisciplinary teams continue to push the boundaries of excellence. #RMPatPM #Research #Education #PatientCare.

using AI to develop a new treatment plan within minutes rather than traditional timelines (days). The launch of this technology represents a paradigm shift in how planning and adaptive radiotherapy delivery is performed @DKirschMDPhD @UHN @pmcancercentre.

We have successfully treated prostate and sarcoma patients, with other sites including liver, gynae, head and neck, to follow in the future. This tech allows us to drastically compress our typical radiation therapy workflow timelines and offer personalized precision radiotherapy.

On Feb 4, 2025, the Varian Ethos 2.0 Adaptive Radiation Therapy platform went live, thanks to the dedicated efforts of RMP staff. Our team of Medical Physicists, Radiation Oncologists, and Radiation Therapists spent 4 months preparing for a safe launch for our first patients.

RT @AEPatPM: 🚨 Registration is OPEN for IURTTA 2025! 🚨 Join us for the International Undergraduate Radiation Therapist Training Academy (IU….

Read more on the projects here: @DKirschMDPhD @aleberlin2 @jseuntje @YatTsang .@PMResearch_UHN @pmcancercentre @UHN.

🎉 Congrats to Drs. Monica Serban, @BenLok & @brokendna on their @CIHR_IRSC Project Grants! The projects will advance care and knowledge in radiation therapy side effects in cervical cancer, novel therapy for small cell lung , and mechanisms of treatment response in cancer cells.

RT @RadMedPM: On #WomenInScience Day, we celebrate the incredible women powering cancer research, education & treatment worldwide! 🌍💙At @Ra….

On #WomenInScience Day, we celebrate the incredible women powering cancer research, education & treatment worldwide! 🌍💙At @RadMedPM @pmcancercentre @UHN, we’re proud to advance innovation, hope & compassionate care. #GirlsInScience #WomenInSTEM.